Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox and Steroids for Hypertrophic Scars and Keloids
NCT03982862Phase 4Unknown
- Sponsor
- Kaohsiung Medical University
- Start
- Jul 2018
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of botulinum toxin type A in Hypertrophic Scar (HS) and keloid (2 arms), sponsored by Kaohsiung Medical University. Primary endpoints: Scar pain relief at 16 weeks, Scar appearance at 16 weeks and 1 more. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
Hypertrophic Scar (HS)keloid
Beyond the preview
Go deeper on NCT03982862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03982862.